[topsearch__bar__shortcode]

February 2021

TLIS

Tonix Pharmaceuticals (TNXP) Continues to Rally after licensing Technology for Willi Syndrome

Tonix has licensed technology from the French National Institute of Health and Medical Research (Inserm). Shares of Tonix Pharmaceuticals (TNXP) have since the start of February 2021. On Monday, the shares soared over 22% following the announcement to develop a COVID-19 skin test. Once again, the stock is rolling, but this time with another important

Tonix Pharmaceuticals (TNXP) Continues to Rally after licensing Technology for Willi Syndrome Read More »

XPO

The Three Best Logistic Stocks for the long-term Investment

The logistic stocks would be a decent bet for the long run as online delivery services are emerging faster than ever. The logistics firms are expected to have more workload this year than in 2020.The global pandemic had affected the operations of logistic firms—just like any other company that works on-ground. However, the logistic operations

The Three Best Logistic Stocks for the long-term Investment Read More »

RIVN Stock

The Three Top Consumer Stocks that should be on your Watch List

The consumer stocks are mostlya long-term option for investors, with usually high dividend yields. Consumer stocks held up well last year, and on reasonable grounds. When the pandemic reached its peak in March, daily life product sales soared as people got panic with a potential threat of supply issues. Looking into this year’s probability of

The Three Top Consumer Stocks that should be on your Watch List Read More »

REVB Stock

What the sentiment indicator is telling us: Gamida Cell Ltd. [GMDA]

Gamida Cell Ltd. (Nasdaq: GMDA) stock was surging up 55.21% to reach $15.35 in the pre-market session. Over the past 3 months, the company’s stock has gone up 69.06%. With a 12-month market performance over 111.32% higher, GMDA shares are trading 17.88% higher year to date (YTD). Company Profile Gamida Cell is a cell therapy

What the sentiment indicator is telling us: Gamida Cell Ltd. [GMDA] Read More »